CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

Bhattarai, Shanta; Mackeyev, Yuri; Venkatesulu, Bhanu P.; Krishnan, Sunil; Singh, Pankaj K.

doi:10.1039/d1nr05385j

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

CXC chemokine receptor 4 (CXCR4) is overexpressed on most breast cancer cell surfaces including triple negative breast cancer (TNBC) which lacks traditional receptor overexpression.